International Flavors & Fragrances Inc. reports developments across flavors, fragrances, food ingredients, health and biosciences for customers in food, beverage, personal care, home care, pet health and related markets. News frequently covers ingredient innovation, application labs and natural-extraction capabilities, including vanilla work in Madagascar and LMR Naturals in perfumery, cosmetics and flavors.
Company updates also address probiotics and bioscience products such as HOWARU Pet and PureStrong, nutrition claims tied to soy protein, quarterly earnings releases, dividends, and other capital or financial disclosures.
IFF has entered into a $1.3 billion agreement to sell its Microbial Control business unit to LANXESS. The proceeds will primarily be used to reduce outstanding debt, enhancing IFF’s financial profile. The Microbial Control unit generated approximately $440 million in annual revenue and $85 million in EBITDA in 2021, focusing on preservation and hygiene solutions across various industries. IFF aims for a seamless transition, expecting the deal to close in the second quarter of 2022, subject to regulatory approvals.
International Flavors & Fragrances reported Q2 2021 results with revenue of $3.1 billion, representing a 158% increase year-over-year, primarily due to the merger with Nutrition & Biosciences. Adjusted operating EBITDA reached $679 million, up 184%, while EPS was $0.11 or $1.50 excluding amortization. The firm anticipates 7% growth for the full year and has increased its quarterly dividend by 3%, marking its twelfth consecutive year of hikes. Despite strong cash flow generation, margins faced pressures from rising raw material costs.
IFF (NYSE: IFF) has appointed Nicolas Mirzayantz as the new President of its Nourish division, effective September 1, 2021. He succeeds Kathy Fortmann, who is leaving to explore other opportunities. Mirzayantz brings extensive experience from his previous role as President of the Scent division, where he achieved a 5% compound annual growth rate. Christophe de Villeplee will take over Mirzayantz's former role as President of Scent. The leadership transition aims to leverage IFF's strong product portfolio and innovation to drive growth in the global food and beverage sector.
IFF (NYSE:IFF) will release its second quarter 2021 earnings results on August 5, 2021, after market close. A live webcast will take place on August 6, 2021, at 10:00 a.m. ET, to discuss the results and outlook. Investors can access both the live and recorded versions of the webcast on the Company's website.
As a leader in food, beverage, scent, health, and biosciences, IFF focuses on combining science and creativity to deliver innovative solutions that meet global demand.
On May 20, 2021, IFF (NYSE: IFF) launched its Science of Wellness program in response to consumer demand for holistic wellbeing solutions. This initiative leverages over forty years of fragrance research and advanced AI technology to create scents that offer emotional and cognitive benefits. The wellness market is expected to grow annually by 5 to 10% by 2025. An IFF study indicated that 87% of consumers prefer fragrances with wellness benefits. The program aims to innovate in fragrance design, utilizing extensive data to inform product development.
Summary not available.
International Flavors & Fragrances reported Q1 2021 results with net sales of $2.47 billion, an 83% increase year-over-year, primarily due to its merger with Nutrition & Biosciences. Adjusted EBITDA rose 88% to $569 million, while reported EPS was $(0.21). The company plans to divest its fruit preparation business, expected to close in Q3 2021, contributing about $70 million in sales.
The updated 2021 sales guidance is approximately $11.25 billion, with an adjusted operating EBITDA margin of ~23%.
IFF (NYSE: IFF) has declared a quarterly cash dividend of $0.77 per share, scheduled for payment on July 6, 2021. Shareholders on record as of June 25, 2021 will receive this dividend. This decision reflects the company's commitment to returning value to its shareholders while continuing to operate as a leader in the food, beverage, scent, health, and biosciences sectors. IFF emphasizes its dedication to sustainability and innovation in creating solutions for enhancing both consumer experiences and environmental responsibility.
IFF (NYSE:IFF) will announce its first quarter 2021 earnings results after market closure on May 10, 2021. A live webcast for investors will be held on May 11, 2021, at 10:00 a.m. ET, where the management team will discuss the results and future outlook. The webcast and a presentation will be accessible on the company’s website at ir.iff.com, with a recorded version available for those unable to attend live.
IFF has launched a new video series, “Learning Labs,” showcasing discussions with its leadership on the company's segments and R&D functions. This initiative follows IFF's merger with DuPont's Nutrition and Biosciences, aiming to increase transparency and stakeholder communication. Additionally, IFF has provided segment-level financial details for 2020 based on pro forma results, highlighting sales and adjusted EBITDA across its four segments. Chairman and CEO Andreas Fibig emphasized the importance of connecting with investors and showcasing IFF's growth potential.